Medroxyprogesterone depot - Pfizer

Drug Profile

Medroxyprogesterone depot - Pfizer

Alternative Names: depo medroxyprogesterone acetate; Depo subQ in Uniject; Depo-subQ provera 104; DMPA -Pfizer; DMPA-SC; Medroxiprogesterone acetate; Sayana; Sayana Press; Sayana press

Latest Information Update: 17 Jan 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pfizer
  • Class Anti-inflammatories; Antineoplastics; Hormonal replacements; Progesterone congeners; Progestogen-only oral contraceptives
  • Mechanism of Action Interleukin 6 receptor antagonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Pain; Pregnancy
  • Registered Endometriosis

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 17 Jan 2018 No development reported - Preregistration for Pregnancy (Prevention) in Pakistan (SC)
  • 09 Dec 2015 Launched for Pregnancy (Prevention) in Bangladesh (SC) before December 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top